Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis
Фаза 3 – широко изпитване преди одобрение
Заболявания:
Generalized Myasthenia Gravis
Спонсор: UCB Biopharma SRL
Налично на:
БГ
Обобщение
The RAISE-XT study is an open-label extension study to evaluate the long-term efficacy, safety, and tolerability of zilucoplan in subjects with gMG who have previously participated in a qualifying Ra Pharmaceuticals sponsored zilucoplan study.
Кой може да участва
Inclusion Criteria:
* Completion of a qualifying zilucoplan study
Exclusion Criteria:
* With the exception of a prior zilucoplan trial, participation in another concurrent clinical trial involving an experimental therapeutic intervention (participation in observational studies and/or registry studies is permitted)
БГ
EN